Hyponatremia Plus Fluid Overload Ups Death Risk in Dialysis Population
Findings are based on a study including more than 72,000 patients on hemodialysis from 25 countries.
Findings are based on a study including more than 72,000 patients on hemodialysis from 25 countries.
This is an abridged version of the World Kidney Day 2023 scientific editorial published in Kidney International.
Upward trend follows debut of the federal End-Stage Renal Disease Treatment Choices payment model in January 2021.
The ratio is a clinically meaningful indicator that is easily obtained from blood test results, according to investigators.
Bloodstream infections overall in the dialysis population have decreased since 2014, according to a CDC report.
The FDA approval of daprodustat is based on results from the ASCEND-D trial comparing daprodustat with ESAs.
Study findings support The End-Stage Renal Disease Quality Incentive Program’s composite measure of facility performance, which is revised annually.
Black patients without high-risk APOL1 alleles did not have higher risks for kidney failure.
Furthermore, use of anticoagulants induces higher incidence of GI bleeding in hemodialysis versus peritoneal dialysis patients
GDF-15 adds predictive value to the HAS-BLED score for assessing major bleeding risk.